OptimizeRx Corporation
OPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $379,653 | $249,896 | $159,957 | $89,514 |
| - Cash | $19,519 | $16,585 | $16,573 | $13,380 |
| + Debt | $3,807 | $28,975 | $32,800 | $33,193 |
| Enterprise Value | $363,941 | $262,286 | $176,184 | $109,327 |
| Revenue | $26,067 | $29,195 | $21,928 | $32,316 |
| % Growth | -10.7% | 33.1% | -32.1% | – |
| Gross Profit | $17,516 | $18,635 | $13,344 | $22,023 |
| % Margin | 67.2% | 63.8% | 60.9% | 68.1% |
| EBITDA | $3,144 | $4,390 | -$893 | $4,865 |
| % Margin | 12.1% | 15% | -4.1% | 15.1% |
| Net Income | $779 | $1,532 | -$2,199 | -$78 |
| % Margin | 3% | 5.2% | -10% | -0.2% |
| EPS Diluted | 0.04 | 0.081 | -0.12 | 0 |
| % Growth | -50.4% | 167.2% | – | – |
| Operating Cash Flow | $3,202 | $4,561 | $3,864 | $198 |
| Capital Expenditures | -$10 | -$10 | -$27 | -$120 |
| Free Cash Flow | $3,192 | $4,551 | $3,837 | $78 |